Skip to main content

News

Appointment at Towers Perrin

Towers Perrin has promoted four of its Tillinghast European senior consultants to principal. Geoffre...

Alarm announces new CEO

Alarm – The National Forum for Risk Management in the Public Sector – has announced the appointment of Simon Wills as its new chief executive.

Willis to purchase £33m Irish broker

Broker Willis has reached agreement in principle to acquire a majority shareholding in Coyle Hamilton, rebranding it Coyle Hamilton Willis, and merging Willis' existing Irish operations into the group.

Kiln bullish in 2004 forecast

Lloyd's insurer Kiln is predicting its 2004 year of account will exceed the performance of its business in the previous year, when it acheived a market leading combined ratio of 77% and profits of £33.1m.

Swiss Re renews BFIS pledge

Swiss Re has renewed its $100,000 funding pledge for the Bermuda Foundation For Insurance Studies (BFIS) scholarship programme over a further five years.

General insurance growth at 5.3% across EU

The number of insurance companies in Europe has remained stable at around 5000 with general insurance premiums rising by 5.3% in 2003 despite the trend towards concentration, according to Gérard de La Martinière, president of the Comité Européen des…

Primary broker start up aims for top spot

Primary subsidiary Health for Industry has launched a dedicated offshore and international private medical insurance broker.  The company, Health for Industry International Limited, is based in Guernsey and licensed by the Guernsey Financial Services…

Ace appoints Kramer

Ace has announced that Donald Kramer has been appointed executive, office of the president & chief executive officer, effective immediately.

Buffett linked with Lloyd's IPO

American investment guru Warren Buffett has been linked with a major investment in Lloyd’s insurer Euclidian when it announces plans for its long awaited floatation.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here